These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 25659076

  • 1. Markers of bone metabolism are affected by renal function and growth hormone therapy in children with chronic kidney disease.
    Doyon A, Fischer DC, Bayazit AK, Canpolat N, Duzova A, Sözeri B, Bacchetta J, Balat A, Büscher A, Candan C, Cakar N, Donmez O, Dusek J, Heckel M, Klaus G, Mir S, Özcelik G, Sever L, Shroff R, Vidal E, Wühl E, Gondan M, Melk A, Querfeld U, Haffner D, Schaefer F, 4C Study Consortium.
    PLoS One; 2015; 10(2):e0113482. PubMed ID: 25659076
    [Abstract] [Full Text] [Related]

  • 2. Paediatric reference values for the C-terminal fragment of fibroblast-growth factor-23, sclerostin, bone-specific alkaline phosphatase and isoform 5b of tartrate-resistant acid phosphatase.
    Fischer DC, Mischek A, Wolf S, Rahn A, Salweski B, Kundt G, Haffner D.
    Ann Clin Biochem; 2012 Nov; 49(Pt 6):546-53. PubMed ID: 22984195
    [Abstract] [Full Text] [Related]

  • 3. Relationship between serum sclerostin, bone metabolism markers, and bone mineral density in maintenance hemodialysis patients.
    Ishimura E, Okuno S, Ichii M, Norimine K, Yamakawa T, Shoji S, Nishizawa Y, Inaba M.
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4315-20. PubMed ID: 25093620
    [Abstract] [Full Text] [Related]

  • 4. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
    Lerch C, Shroff R, Wan M, Rees L, Aitkenhead H, Kaplan Bulut I, Thurn D, Karabay Bayazit A, Niemirska A, Canpolat N, Duzova A, Azukaitis K, Yilmaz E, Yalcinkaya F, Harambat J, Kiyak A, Alpay H, Habbig S, Zaloszyc A, Soylemezoglu O, Candan C, Rosales A, Melk A, Querfeld U, Leifheit-Nestler M, Sander A, Schaefer F, Haffner D, 4C study consortium, ESPN CKD-MBD working group.
    Nephrol Dial Transplant; 2018 Dec 01; 33(12):2208-2217. PubMed ID: 29481636
    [Abstract] [Full Text] [Related]

  • 5. Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity.
    Grethen E, Hill KM, Jones R, Cacucci BM, Gupta CE, Acton A, Considine RV, Peacock M.
    J Clin Endocrinol Metab; 2012 May 01; 97(5):1655-62. PubMed ID: 22362819
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the activity of tartrate-resistant acid phosphatase isoform 5b in normal Chinese children--a novel marker for bone growth.
    Chen CJ, Chao TY, Janckila AJ, Cheng SN, Ku CH, Chu DM.
    J Pediatr Endocrinol Metab; 2005 Jan 01; 18(1):55-62. PubMed ID: 15679069
    [Abstract] [Full Text] [Related]

  • 7. Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis.
    Malluche HH, Davenport DL, Cantor T, Monier-Faugere MC.
    Clin J Am Soc Nephrol; 2014 Jul 01; 9(7):1254-62. PubMed ID: 24948144
    [Abstract] [Full Text] [Related]

  • 8. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY, Milovanov YS, Kudryavtseva DV, Markina MM, Milovanova SY, Kozlovskaya LV, Lebedeva MV, Beketov VD, Moiseev SV, Mukhin NA, Fomin VV, Svistunov AA.
    Ter Arkh; 2015 Jul 01; 87(6):10-16. PubMed ID: 26281189
    [Abstract] [Full Text] [Related]

  • 9. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F, Mawad H, El-Husseini AA, Davenport DL, Malluche HH.
    Clin Nephrol; 2019 Apr 01; 91(4):222-230. PubMed ID: 30862350
    [Abstract] [Full Text] [Related]

  • 10. The clinical utility of serum tartrate-resistant acid phosphatase 5b in the assessment of bone resorption in patients on peritoneal dialysis.
    Yamada S, Tsuruya K, Yoshida H, Taniguchi M, Haruyama N, Tanaka S, Eriguchi M, Nakano T, Kitazono T.
    Clin Endocrinol (Oxf); 2013 Jun 01; 78(6):844-51. PubMed ID: 23078546
    [Abstract] [Full Text] [Related]

  • 11. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
    Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Högler W.
    J Clin Endocrinol Metab; 2007 Feb 01; 92(2):443-9. PubMed ID: 17105843
    [Abstract] [Full Text] [Related]

  • 12. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction.
    Yamada S, Inaba M, Kurajoh M, Shidara K, Imanishi Y, Ishimura E, Nishizawa Y.
    Clin Endocrinol (Oxf); 2008 Aug 01; 69(2):189-96. PubMed ID: 18221403
    [Abstract] [Full Text] [Related]

  • 13. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H, Cui Y, Xing C, Purrunsing Y, Zha X, Shen C, Zeng M, Yang G, Yu X, Zhang L, Jiang Y, Shen Z, Ma H, Yin C, Li Y, Wang N.
    Int Urol Nephrol; 2018 Dec 01; 50(12):2279-2288. PubMed ID: 30361964
    [Abstract] [Full Text] [Related]

  • 14. Increase in circulating sclerostin at the early stage of menopausal transition in Japanese women.
    Matsui S, Yasui T, Kasai K, Keyama K, Kato T, Uemura H, Kuwahara A, Matsuzaki T, Irahara M.
    Maturitas; 2016 Jan 01; 83():72-7. PubMed ID: 26508082
    [Abstract] [Full Text] [Related]

  • 15. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC, Ma WY, Yu JC, Wu CC, Chu P.
    Clin Endocrinol (Oxf); 2012 May 01; 76(5):634-42. PubMed ID: 22007930
    [Abstract] [Full Text] [Related]

  • 16. Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women.
    Costa AG, Walker MD, Zhang CA, Cremers S, Dworakowski E, McMahon DJ, Liu G, Bilezikian JP.
    J Clin Endocrinol Metab; 2013 Dec 01; 98(12):4736-43. PubMed ID: 24037879
    [Abstract] [Full Text] [Related]

  • 17. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO, Hecking M, Plischke M, Cejka D, Kieweg H, Haas M, Marculescu R, Hörl WH, Bieglmayer C, Sunder-Plassmann G.
    Clin Biochem; 2014 Sep 01; 47(13-14):1316-9. PubMed ID: 24956265
    [Abstract] [Full Text] [Related]

  • 18. Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.
    Małyszko J, Małyszko JS, Pawlak K, Wołczyński S, Myśliwiec M.
    Adv Med Sci; 2006 Sep 01; 51():69-72. PubMed ID: 17357281
    [Abstract] [Full Text] [Related]

  • 19. Effect of Aerobic Exercise on Markers of Bone Metabolism of Overweight and Obese Patients With Chronic Kidney Disease.
    Gomes TS, Aoike DT, Baria F, Graciolli FG, Moyses RMA, Cuppari L.
    J Ren Nutr; 2017 Sep 01; 27(5):364-371. PubMed ID: 28606422
    [Abstract] [Full Text] [Related]

  • 20. Influence of Parathyroidectomy on Bone Metabolism and Bone Pain in Patients with Secondary Hyperparathyroidism.
    Schneider R, Steinmetz C, Karakas E, Bartsch DK, Schlosser K.
    Eur Surg Res; 2018 Sep 01; 59(1-2):35-47. PubMed ID: 29393259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.